Skip to main content
Prescription only

AFSTYLA Antihemophilic Factor (Recombinant), Single Chain

ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT

Listed by CSL Behring Lengnau AG

Form
Kit

What it contains

No active ingredients listed in the FDA record.

FDA record

Dosage form Kit
Approval route BLA — biologic licence
NDC code 69911-478
FDA application BLA125591
Package sizes listed 1
Marketed since May 2016

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.